Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report.
Adult
Antipsychotic Agents
Comorbidity
Delayed-Action Preparations
/ therapeutic use
Drug Therapy, Combination
Humans
Injections, Intramuscular
Male
Obsessive-Compulsive Disorder
/ drug therapy
Paliperidone Palmitate
/ administration & dosage
Piperazines
/ therapeutic use
Schizophrenia
/ epidemiology
Journal
International clinical psychopharmacology
ISSN: 1473-5857
Titre abrégé: Int Clin Psychopharmacol
Pays: England
ID NLM: 8609061
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
16
1
2021
Statut:
ppublish
Résumé
Obsessive-compulsive disorder is often associated with schizophrenia and may represent a significant challenge in the treatment as this comorbidity may not respond properly to antipsychotic medication and usually require a pharmacological and psychotherapeutic add-on. In the present case report, we present the case of a 26-year-old male blue-collar subject who developed obsessive-compulsive disorder after a year of complete remission of schizophrenia symptoms under paliperidone long-acting injection that rapidly resolved after low-dosage cariprazine add-on. No adverse effects were reported due to cariprazine- paliperidone long-acting injection combination.
Identifiants
pubmed: 32004167
doi: 10.1097/YIC.0000000000000284
pii: 00004850-202003000-00009
doi:
Substances chimiques
Antipsychotic Agents
0
Delayed-Action Preparations
0
Piperazines
0
cariprazine
F6RJL8B278
Paliperidone Palmitate
R8P8USM8FR
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM